Highlights GSK plc

Equities

Market Closed - London S.E. Other stock markets 11:35:04 2024-05-31 am EDT			5-day change	1st Jan Change
1,766 ^GBX	+2.11%		-0.45%	+21.81%

09:35am	GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	RE
May. 31	US FDA approves Moderna's RSV vaccine, its second marketed product	RE

GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal	03:35am	RE
US FDA approves Moderna's RSV vaccine, its second marketed product	May. 31	RE
US nears deal to fund Moderna's bird flu vaccine trial, FT reports	May. 30	RE
CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate	May. 28	MT
Rate outlook weighs on equities	May. 24
GSK: successful verdict in Zantac case	May. 24	CF
GSK: to present its advances in oncology at ASCO	May. 24	CF
FTSE 100 falls; retail sales plunge in April	May. 24	AN
GSK celebrates Illinois jury verdict in Valadez case	May. 24	AN
GSK to Continue Vigorous Defense of Zantac Cancer Claims After Recent US Victory	May. 24	MT
UK retail sales fall amid wet April; Co-Op Bank deal	May. 24	AN
GSK Says Illinois Jury Finds Heartburn Drug Zantac Not Liable for Plaintiff's Cancer	May. 24	DJ
GSK, Boehringer Ingelheim Bag Win in Zantac Cancer Case US Trial	May. 24	MT
Sector Update: Health Care Stocks Retreat Late Afternoon	May. 23	MT
Sector Update: Health Care	May. 23	MT
GSK's Zantac Didn't Cause Woman's Cancer, Chicago Jury Verdict Says	May. 23	MT
GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link	May. 23	MT
GSK's Zantac Cleared in Chicago Jury Trial for Alleged Colon Cancer Link	May. 23	MT
GSK on Zantac Litigation Says Will Continue To "Vigorously Defend" Itself Against All Claims	May. 23	RE
GSK - VERDICT CONSISTENT WITH SCIENTIFIC CONSENSUS THAT THERE IS…	May. 23	RE

No results for this search

GSK plc : Back on track

May 03, 2024 at 05:17 am EDT

GSK PLC : Encouraging start to 2024; guidance raised